A licensed clinician can order ketamine for approved anesthesia uses, and may use it “off label” in clinics under careful monitoring where local rules allow.
Ketamine has a split reputation. In hospitals, it’s a standard anesthetic. Outside that setting, it’s sometimes marketed in ways that can add risk. If you’re asking about prescriptions, you likely want to know what’s allowed and what’s smart.
Below, you’ll see the three common lanes: FDA-approved ketamine for anesthesia, FDA-approved esketamine (Spravato) under a restricted program, and compounded ketamine products that some clinics sell for mood or pain. The goal is simple: help you spot safe care and skip risky setups.
Can A Doctor Prescribe Ketamine?
Yes—doctors and other qualified prescribers can legally order ketamine when they hold the right license and follow controlled-substance rules. In the United States, ketamine is a Schedule III controlled substance. That status allows medical use, plus tighter prescribing and recordkeeping than routine meds.
What “prescribe” means depends on the setting. In a hospital, ketamine is often administered by injection as part of anesthesia or procedural sedation. In outpatient care, you might hear “ketamine therapy,” which can mean supervised infusions, supervised intramuscular dosing, or (in some clinics) compounded lozenges or nasal sprays. The legal path can exist, yet the safety path can differ a lot from one clinic to the next.
What Ketamine Is Approved For Versus How It’s Used
In the U.S., ketamine hydrochloride injection (brand example: Ketalar) is FDA-approved as an anesthetic agent for certain diagnostic and surgical procedures. The official label spells out indications, dosing ranges, and warnings for anesthesia care. KETALAR (ketamine) prescribing information is the cleanest reference for what the drug is approved to do.
“Off label” use is different. A clinician may use an approved drug for a purpose not listed on the FDA label when their medical judgment and local rules allow it. That practice is legal in many places, yet it places a bigger burden on the clinic to show careful selection, monitoring, dosing discipline, and follow-up.
Then there’s esketamine (Spravato), a ketamine-related medicine that is FDA-approved for specific depression indications and must be given in a certified health-care setting under a REMS safety program. The restricted distribution rules are part of why Spravato is not handed out for home dosing. SPRAVATO REMS program requirements lay out that certified-site approach.
Why The “Schedule” Label Matters
Controlled-substance scheduling affects who can prescribe, how prescriptions are documented, and how the drug is stored and dispensed. The DEA’s own materials describe ketamine’s Schedule III status and accepted medical uses. DEA ketamine drug fact sheet is a plain-language snapshot of those rules.
Scheduling isn’t a stamp that a use is “right.” It’s a legal category. Safety still comes down to dose, screening, monitoring, and what happens after the session ends.
Taking Ketamine Outside The Operating Room
In outpatient care, ketamine is most often discussed for depression that hasn’t responded to standard treatments, certain pain syndromes, and acute suicidality in tightly supervised settings. Research in these areas is active, and clinic protocols can differ a lot.
One clinic may run hospital-style monitoring, keep emergency meds on hand, and require a ride home. Another may hand out compounded lozenges for home use with light screening. That gap is where risk shows up.
Clinic-Based Dosing
When ketamine is administered in a clinic (IV infusion, IM injection, or supervised oral dosing), good practice usually includes baseline vitals, active observation during the session, and a recovery period until you’re steady on your feet. Sedation and dissociation are known effects, so a ride home and no driving the same day are standard safety steps.
Compounded Ketamine Products
Compounding pharmacies can prepare ketamine in forms not sold as FDA-approved products, like lozenges or nasal sprays. Compounding can be appropriate when a patient needs a specific formulation. Yet marketing compounded ketamine for psychiatric disorders is where regulators have raised sharp cautions. The FDA states that ketamine is not FDA-approved for treating any psychiatric disorder and warns about risks tied to compounded ketamine products. FDA warning on compounded ketamine explains the concern.
If a clinic’s plan depends on home dosing with compounded ketamine, treat the protocol as higher-risk until it earns trust. Ask what safety steps replace on-site monitoring, how adverse events are handled, and how dosing is kept conservative.
Can A Doctor Prescribe Ketamine For Depression And Pain?
Many clinicians do use ketamine “off label” in specialty clinics for depression and some pain conditions, and some physicians prescribe compounded forms. Whether that is permitted and how it is regulated depends on your country, and in the U.S. it can depend on your state and the clinician’s license type.
For depression in the U.S., it helps to separate two routes:
- Esketamine (Spravato): FDA-approved for certain indications and administered only in certified settings under REMS controls.
- Ketamine (racemic ketamine): FDA-approved as an anesthetic, then used “off label” by some clinics for mood symptoms under their own protocols.
For pain, ketamine may be used in anesthesia and peri-operative settings, and some pain clinics use it in infusion protocols. The right question is less “Can it be prescribed?” and more “What guardrails are in place for my case?”
Safety Checks That Separate Serious Care From Risky Care
Ketamine can raise blood pressure, alter perception, and impair coordination for hours. Those effects mean a clinic needs a real plan, not just a waiver and a payment link. If you’re comparing providers, use these checks to spot a protocol built around patient safety.
Screening Before A First Dose
A careful intake often includes:
- Medication review, including sedatives, stimulants, and substances that can raise blood pressure.
- History of heart disease, uncontrolled hypertension, glaucoma risk, or seizure disorders.
- Past reactions to anesthesia or dissociative drugs.
- Current substance-use history and any past misuse of ketamine or similar drugs.
Monitoring During The Session
Ask what’s measured and who is present. In many infusion clinics, staff track blood pressure, pulse, oxygen saturation, and mental status during dosing and recovery. If the clinic says monitoring isn’t needed, treat that as a warning sign.
Recovery Rules After The Session
Safe clinics set boundaries: no driving the same day, no heavy machinery, no solo childcare immediately after dosing, and a ride home arranged in advance. You should leave with written after-care instructions and a contact method for urgent questions.
Where Ketamine Is Given And What That Means
Route and setting shape both risk and oversight. A ketamine injection in a hospital operating suite is a different scenario than a mailed lozenge taken at home. The table below compares common patterns you might encounter.
| Setting Or Route | What Patients Usually Receive | Guardrails That Matter |
|---|---|---|
| Hospital anesthesia | IV or IM ketamine for induction or sedation | Continuous monitoring, trained airway staff, resuscitation tools |
| Emergency or procedural sedation | Ketamine for short procedures | Vitals tracked, recovery until alert, discharge criteria |
| Outpatient infusion clinic | IV ketamine infusion series | Screening, monitored dosing, ride-home rule, written after-care |
| Pain clinic infusion | IV ketamine with pain-focused protocol | Clear dose limits, monitoring, medication interaction checks |
| Supervised intranasal esketamine | Spravato in a certified setting | REMS enrollment, on-site administration, observation period |
| Supervised oral dosing on site | Oral ketamine in clinic | Observed onset and recovery, conservative titration |
| Compounded troches at home | Lozenges or other compounded forms | Clear dosing plan, strict follow-up, strong misuse safeguards |
| Telehealth + shipped ketamine | Home ketamine program | High scrutiny needed: screening depth, emergency plan, misuse controls |
How To Talk With Your Clinician About Ketamine
If you’re already under care for depression, pain, or another condition, bring ketamine up directly and keep it practical. Say what you’ve tried, what didn’t work, and what outcomes you want tracked (sleep, function, pain scores, suicidal thoughts, or ability to work).
Ask what options exist in your area: hospital-based care, an infusion clinic with medical monitoring, or FDA-approved esketamine under REMS. If your clinician suggests compounded ketamine, ask how they chose that route, what data they rely on, and what safeguards they use to reduce misuse and medical complications.
A Checklist To Use Before You Commit
Save this list. If a clinic can’t answer these items, don’t start dosing there.
- Prescriber credentials and licensing are clear.
- Written protocol with dose ranges, monitoring plan, and discharge rules.
- Plan for blood pressure spikes and distress during dosing.
- Clear rule: no driving the same day, ride home arranged.
- Follow-up plan between sessions and after the series ends.
- Transparent pricing with no pressure tactics.
Common Outcomes And Side Effects To Expect
During a session, people often feel detached, dizzy, or nauseated. Blood pressure can rise. Most clinics keep you on site until you’re steady, then send you home with a no-driving rule.
If ketamine is being used for mood symptoms, some people feel relief within hours or days. Others don’t. Track how you sleep, how you function, and how long any change lasts so dosing decisions are based on your data, not hype.
| What You Notice | What A Good Clinic Does | What You Can Do |
|---|---|---|
| Nausea or vomiting | Offers anti-nausea options, adjusts timing and dose | Arrive with a light food plan, tell staff early |
| Blood pressure rise | Checks vitals, pauses or lowers dose if needed | Share BP history and meds up front |
| Distress during dissociation | Preps you, stays present, uses a calming protocol | Use breathing cues, ask for a lower dose next time |
| Headache or fatigue later | Gives after-care guidance and follow-up | Rest, hydrate, avoid hard tasks that day |
| Short-lived mood lift | Tracks symptoms, adjusts spacing, sets a realistic plan | Log mood and sleep between visits |
| No response after several sessions | Reassesses treatment fit and “stop” criteria | Ask what comes next if it doesn’t help |
Making A Safe Call
A doctor can prescribe ketamine in the right setting, and in many places clinicians can use it “off label.” The part that decides whether it’s a smart move is the clinic’s protocol. Look for real medical screening, real monitoring, and a clear plan for adverse effects. Skip any provider that treats ketamine like a casual subscription.
References & Sources
- U.S. Food and Drug Administration (FDA).“KETALAR (ketamine hydrochloride) Injection: Prescribing Information.”Lists approved indications, dosing guidance, and warnings for ketamine used as an anesthetic.
- Drug Enforcement Administration (DEA).“Ketamine Drug Fact Sheet.”Describes ketamine’s Schedule III status in the U.S. and outlines medical uses and risks.
- U.S. Food and Drug Administration (FDA).“FDA Warns Patients And Health Care Providers About Potential Risks Associated With Compounded Ketamine.”Warns about risks tied to compounded ketamine products marketed for psychiatric disorders.
- SPRAVATO REMS Program.“SPRAVATO REMS.”Explains the restricted distribution and on-site administration rules for esketamine nasal spray.
